Literature DB >> 8830310

Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-beta-peptides.

A Alvarez1, F Bronfman, C A Pérez, M Vicente, J Garrido, N C Inestrosa.   

Abstract

Acetylcholinesterase (AChE) colocalizes with amyloid-beta peptide (A beta) deposits present in the brain of Alzheimer's patients. Recent studies showed that A beta 1-40 can adopt two different conformational states in solution (an amyloidogenic conformer, A beta ac, and a non-amyloidogenic conformer, A beta nac) which have distinct abilities to form amyloid fibrils. We report here that AChE binds A beta nac and accelerates amyloid formation by the same peptide. No such effect was observed with A beta ac, the amyloidogenic conformer, suggesting that AChE acts as a 'pathological chaperone' inducing a conformational transition from A beta nac into A beta ac in vitro.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8830310     DOI: 10.1016/0304-3940(94)12127-c

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Synthesis and in silico evaluation of 1N-methyl-1S-methyl-2-nitroethylene (NMSM) derivatives against Alzheimer disease: to understand their interacting mechanism with acetylcholinesterase.

Authors:  M Kannan; P Manivel; K Geetha; J Muthukumaran; H Surya Prakash Rao; R Krishna
Journal:  J Chem Biol       Date:  2012-09-20

2.  Acetylcholinesterase protein level is preserved in the Alzheimer's brain.

Authors:  María-Letizia Campanari; María-Salud García-Ayllón; Lidia Blazquez-Llorca; Wilson K W Luk; Karl Tsim; Javier Sáez-Valero
Journal:  J Mol Neurosci       Date:  2013-12-07       Impact factor: 3.444

3.  Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils.

Authors:  A Alvarez; R Alarcón; C Opazo; E O Campos; F J Muñoz; F H Calderón; F Dajas; M K Gentry; B P Doctor; F G De Mello; N C Inestrosa
Journal:  J Neurosci       Date:  1998-05-01       Impact factor: 6.167

4.  Cholinesterase inhibitors for the treatment of Alzheimer's disease:: getting on and staying on.

Authors:  George T Grossberg
Journal:  Curr Ther Res Clin Exp       Date:  2003-04

Review 5.  Inclusion body myositis: a view from the Caenorhabditis elegans muscle.

Authors:  Daniela L Rebolledo; Alicia N Minniti; Paula M Grez; Ricardo Fadic; Rebecca Kohn; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2008-09-05       Impact factor: 5.590

6.  Heparan sulfate proteoglycan induces the production of NO and TNF-alpha by murine microglia.

Authors:  Simona Bussini; Lucia Meda; Elio Scarpini; Emilio Clementi; Giancarlo Conti; Marco Tiriticco; Nereo Bresolin; Pierluigi Baron
Journal:  Immun Ageing       Date:  2005-07-16       Impact factor: 6.400

7.  Synergistic Inhibition of Acetylcholinesterase by Alkaloids Derived from Stephaniae Tetrandrae Radix, Coptidis Rhizoma and Phellodendri Chinensis Cortex.

Authors:  Xiang-Peng Kong; Etta Y L Liu; Zhi-Cong Chen; Miranda Li Xu; Anna X D Yu; Qi-Yun Wu; Ying-Jie Xia; Ran Duan; Tina T X Dong; Karl W K Tsim
Journal:  Molecules       Date:  2019-12-13       Impact factor: 4.411

8.  Chemical Constituents from the Wild Atractylodes macrocephala Koidz and Acetylcholinesterase Inhibitory Activity Evaluation as Well as Molecular Docking Study.

Authors:  Qiannan Zhu; Min Lin; Wanying Zhuo; Yunzhi Li
Journal:  Molecules       Date:  2021-12-01       Impact factor: 4.411

9.  Increased Expression of Readthrough Acetylcholinesterase Variants in the Brains of Alzheimer's Disease Patients.

Authors:  Maria-Letizia Campanari; Francisco Navarrete; Stephen D Ginsberg; Jorge Manzanares; Javier Sáez-Valero; María-Salud García-Ayllón
Journal:  J Alzheimers Dis       Date:  2016-05-30       Impact factor: 4.472

Review 10.  Coumarin-piperazine derivatives as biologically active compounds.

Authors:  Kinga Ostrowska
Journal:  Saudi Pharm J       Date:  2019-12-07       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.